• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of March 20, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Red Blood Cells Leukocytes Reduced
Recall Number B-0627-13
Classification Class II
Code Info 21KS81850; 21KS81876; 21KS81897; 21KS81923; 21KS81935; 21KS81947; 21KS82044; 21KS82070; 21KS82103; 21KS82123; 21KS82126; 21KS82133; 21KS82142; 21KS82158; 21KS82159; 21KS82162; 21KS82165; 21KS82343; 21KS82344; 21KS82485; 21KS82487; 21KY24230; 21KY24248; 21LG75833; 21LG75842; 21LG75852; 21LG75874; 21LG75890; 21LG75920; 21LG75931; 21LG75963; 21LG75981; 21LG75982; 21LK55444; 21LK55449; 21LK55473; 21LL53586; 21LL53593; 21LL53597; 21LL53612; 21LL53616; 21LL54081; 21LL54095; 21LS04243; 21LS04244.
Product Distributed Qty 45 units
Reason For Recall Blood products, possibility sterility compromised and contaminated, were distributed.

Event Detail

Event Id 52256
Product Type Biologics
Status Terminated
Recalling Firm American National Red Cross (The)
City Portland
State OR
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2009-02-12
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern Medical Centers nationwide
-
-